Obesity and vascular complication in percutaneous transfemoral transcatheter aortic valve insertion
Catheterization and Cardiovascular Interventions · 2023
DOI: 10.1002/ccd.30658 ↗Kurz gefasst
Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, 2023. Verfasst von Motahar Hosseini und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Background
Obesity has been associated with an increased risk of vascular complication during percutaneous coronary intervention, but there are no data on the risk of vascular complication during percutaneous transfemoral transcatheter aortic valve insertion (TAVI).
Objectives
We hypothesized there would be a similar increased risk associated with TAVI.
Methods
We reviewed the records of 1176 patients who received percutaneous transfemoral transcatheter aortic valve insertion from September 2015 to September 2020. All patients received 1) preoperative computed tomoraphy angiography assessment of the abdomen and pelvis to delineate iliofemoral artery anatomy, 2) ultrasound‐guided percutaneous femoral arterial access, and 3) pre‐closure of the delivery sheath femoral access site. Vascular complication was recorded based on definitions set forth by Valve Academic Research Consortium 3.
Results
The median age of patients was 81 years, and 60% were men. The median body mass index (BMI) was 29 kg/m 2 (range, 11–67), and 91 (8%) patients had a value ≥40 kg/m 2 (i.e., morbid obesity). Delivery sheath size was 14‐French in 859 (73%) patients, 16‐French in 311 (26%), and 18‐French in 6 (1%). Vascular complication occurred in 53 (5%) patients, including 39 (7%) among the first half of procedures and 14 (2%) among the second half ( p < 0.001). When stratified by obesity status (BMI < or ≥30 kg/m 2 , p < 0.001), the complication rate was 4% in nonobese patients and 5% in obese patients. Multivariable analysis showed no overall association between risk of vascular complication and BMI categories ( p = 0.583)BMI continuous values ( p = 0.529), or sheath size ( p = 0.217).
Conclusions
Obesity is not associated with a vascular complication during percutaneous transfemoral transcatheter aortic valve insertion. The operation should not be denied in obese patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Motahar Hosseini, Mackram F Eleid
Zitieren
APA
Hosseini, M., Lahr, B. D., Greason, K. L., Arghami, A., Gulati, R., Eleid, M. F., & Crestanello, J. A. (2023). Obesity and vascular complication in percutaneous transfemoral transcatheter aortic valve insertion. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30658
Vancouver
Hosseini M, Lahr BD, Greason KL, Arghami A, Gulati R, Eleid MF, et al. Obesity and vascular complication in percutaneous transfemoral transcatheter aortic valve insertion. Catheterization and Cardiovascular Interventions. 2023. doi:10.1002/ccd.30658
BibTeX
@article{Hosseini2023,
author = {Hosseini, Motahar and Lahr, Brian D and Greason, Kevin L and Arghami, Arman and Gulati, Rajiv and Eleid, Mackram F and Crestanello, Juan A},
title = {Obesity and vascular complication in percutaneous transfemoral transcatheter aortic valve insertion},
journal = {Catheterization and Cardiovascular Interventions},
year = {2023},
doi = {10.1002/ccd.30658}
}
EUVIMED